Minerva Biotech raises $4.6M

Wed, 11/17/2010 - 5:41am
Mass High Tech: The Journal of New England Technology

Minerva Biotechnologies Corp. has raised about $4.6 million of planned $5.9 million equity offering, according to a filing with the U.S. Securities and Exchange Commission. In addition to equity, the regulatory filing notes that the Waltham biotech firm is offering warrants that could amount to $1.13 million more.

Minerva focuses on both nanotechnology and stem cell therapeutics. In 2008, the company, alongside the University of California at Santa Barbara, announced they may have found a “pivotal switch” in stem cell differrentiation.  According to researchers, the discovery could lead to big advancements in stem cell treatments and further the understanding of how they operate.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.